Kozek K[au] - Search Results

Year	Number of Results
2000	1
2011	2
2012	1
2013	1
2014	1
2018	2
2019	6
2020	2
2021	1
2022	1

1

Sign Inversion in Photopharmacology: Incorporation of Cyclic Azobenzenes in Photoswitchable Potassium Channel Blockers and Openers.

Trads JB, Hüll K, Matsuura BS, Laprell L, Fehrentz T, Görldt N, Kozek KA, Weaver CD, Klöcker N, Barber DM, Trauner D. Trads JB, et al. Among authors: kozek ka. Angew Chem Int Ed Engl. 2019 Oct 21;58(43):15421-15428. doi: 10.1002/anie.201905790. Epub 2019 Sep 12. Angew Chem Int Ed Engl. 2019. PMID: 31441199 Review.

2

High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel K_V11.1.

Kozek KA, Glazer AM, Ng CA, Blackwell D, Egly CL, Vanags LR, Blair M, Mitchell D, Matreyek KA, Fowler DM, Knollmann BC, Vandenberg JI, Roden DM, Kroncke BM. Kozek KA, et al. Heart Rhythm. 2020 Dec;17(12):2180-2189. doi: 10.1016/j.hrthm.2020.05.041. Epub 2020 Jun 6. Heart Rhythm. 2020. PMID: 32522694 Free PMC article.

3

Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare KCNH2 Variants.

Kozek K, Wada Y, Sala L, Denjoy I, Egly C, O'Neill MJ, Aiba T, Shimizu W, Makita N, Ishikawa T, Crotti L, Spazzolini C, Kotta MC, Dagradi F, Castelletti S, Pedrazzini M, Gnecchi M, Leenhardt A, Salem JE, Ohno S, Zuo Y, Glazer AM, Mosley JD, Roden DM, Knollmann BC, Blume JD, Extramiana F, Schwartz PJ, Horie M, Kroncke BM. Kozek K, et al. Circ Genom Precis Med. 2021 Aug;14(4):e003289. doi: 10.1161/CIRCGEN.120.003289. Epub 2021 Jul 26. Circ Genom Precis Med. 2021. PMID: 34309407 Free PMC article.

4

VU0606170, a Selective Slack Channels Inhibitor, Decreases Calcium Oscillations in Cultured Cortical Neurons.

Spitznagel BD, Mishra NM, Qunies AM, Prael FJ 3rd, Du Y, Kozek KA, Lazarenko RM, Denton JS, Emmitte KA, Weaver CD. Spitznagel BD, et al. Among authors: kozek ka. ACS Chem Neurosci. 2020 Nov 4;11(21):3658-3671. doi: 10.1021/acschemneuro.0c00583. Epub 2020 Oct 14. ACS Chem Neurosci. 2020. PMID: 33143429

5

Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators.

Sharma S, Kozek KA, Abney KK, Kumar S, Gautam N, Alnouti Y, David Weaver C, Hopkins CR. Sharma S, et al. Among authors: kozek ka. Bioorg Med Chem Lett. 2019 Mar 15;29(6):791-796. doi: 10.1016/j.bmcl.2019.01.027. Epub 2019 Jan 23. Bioorg Med Chem Lett. 2019. PMID: 30718161 Free PMC article.

6

Challenges in the Discovery and Optimization of mGlu_2/4 Heterodimer Positive Allosteric Modulators.

Fulton MG, Loch MT, Cuoco CA, Rodriguez AL, Days E, Vinson PN, Kozek KA, Weaver CD, Blobaum AL, Conn PJ, Niswender CM, Lindsley CW. Fulton MG, et al. Among authors: kozek ka. Lett Drug Des Discov. 2019 Dec;16(12):1387-1394. doi: 10.2174/1570180815666181017131349. Lett Drug Des Discov. 2019. PMID: 32201485 Free PMC article.

7

Correction to Analgesic Effects of the GIRK Activator, VU0466551, Alone and in Combination with Morphine in Acute and Persistent Pain Models.

Abney KK, Bubser M, Du Y, Kozek KA, Bridges TM, Lindsley CW, Daniels JS, Morrison RD, Wickman K, Hopkins CR, Jones CK, Weaver CD. Abney KK, et al. Among authors: kozek ka. ACS Chem Neurosci. 2019 May 15;10(5):2621. doi: 10.1021/acschemneuro.9b00165. Epub 2019 Mar 26. ACS Chem Neurosci. 2019. PMID: 30912639 No abstract available.

8

A massively parallel assay accurately discriminates between functionally normal and abnormal variants in a hotspot domain of KCNH2.

Ng CA, Ullah R, Farr J, Hill AP, Kozek KA, Vanags LR, Mitchell DW, Kroncke BM, Vandenberg JI. Ng CA, et al. Among authors: kozek ka. Am J Hum Genet. 2022 Jul 7;109(7):1208-1216. doi: 10.1016/j.ajhg.2022.05.003. Epub 2022 Jun 9. Am J Hum Genet. 2022. PMID: 35688148

9

Large-Scale Synthesis of Gold Nanorods through Continuous Secondary Growth.

Kozek KA, Kozek KM, Wu WC, Mishra SR, Tracy JB. Kozek KA, et al. Among authors: kozek km. Chem Mater. 2013 Nov 26;25(22):10.1021/cm402277y. doi: 10.1021/cm402277y. Chem Mater. 2013. PMID: 24415848 Free PMC article.

10

Bulky adamantanethiolate and cyclohexanethiolate ligands favor smaller gold nanoparticles with altered discrete sizes.

Krommenhoek PJ, Wang J, Hentz N, Johnston-Peck AC, Kozek KA, Kalyuzhny G, Tracy JB. Krommenhoek PJ, et al. Among authors: kozek ka. ACS Nano. 2012 Jun 26;6(6):4903-11. doi: 10.1021/nn3003778. Epub 2012 Jun 15. ACS Nano. 2012. PMID: 22702463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results